Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study-Reference-Cited by-同舟云学术

Increased influenza vaccination rates in patients with autoimmune rheumatic diseases during the Covid-19 pandemic: a cross-sectional study

Published:2021-03-04 Issue:5 Volume:41 Page:895-902
ISSN:0172-8172
Container-title:Rheumatology International
language:en
Short-container-title:Rheumatol Int

Author:

Fragoulis George E.^ORCID,Grigoropoulos Ioannis,Mavrea Evgenia,Arida Aikaterini^ORCID,Bournia Vassiliki-Kalliopi^ORCID,Evangelatos Gerasimos^ORCID,Fragiadaki Kalliopi,Karamanakos Anastasios,Kravvariti Evrydiki^ORCID,Panopoulos Stylianos^ORCID,Pappa Maria,Thomas Konstantinos^ORCID,Tektonidou Maria G.^ORCID,Paraskevis Dimitrios^ORCID,Vassilopoulos Dimitrios^ORCID,Sfikakis Petros P.^ORCID

Publisher

Springer Science and Business Media LLC

Subject

Immunology,Immunology and Allergy,Rheumatology

Link

http://link.springer.com/content/pdf/10.1007/s00296-021-04817-3.pdf

Reference26 articles.

1. Thomas K, Vassilopoulos D (2016) Immunization in patients with inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol 30:946–963. https://doi.org/10.1016/j.berh.2016.10.009

2. Fragoulis GE, Sipsas NV (2019) When rheumatology and infectious disease come together. Ther Adv Musculoskelet Dis. https://doi.org/10.1177/1759720X19868901

3. Furer V, Rondaan C, Heijstek MW, Agmon-Levin N, van Assen S, Bijl M, Breedveld FC, D’Amelio R, Dougados M, Kapetanovic MC, van Laar JM, de Thurah A, Landewe RB, Molto A, Muller-Ladner U, Schreiber K, Smolar L, Walker J, Warnatz K, Wulffraat NM, Elkayam O (2020) 2019 update of EULAR recommendations for vaccination in adult patients with autoimmune inflammatory rheumatic diseases. Ann Rheum Dis 79:39–52. https://doi.org/10.1136/annrheumdis-2019-215882

4. Nakafero G, Grainge MJ, Myles PR, Mallen CD, Zhang W, Doherty M, Nguyen-Van-Tam JS, Abhishek A (2020) Effectiveness of inactivated influenza vaccine in autoimmune rheumatic diseases treated with disease-modifying anti-rheumatic drugs. Rheumatology (Oxford) 59:3666–3675. https://doi.org/10.1093/rheumatology/keaa078

5. Fragoulis GE, Evangelatos G, Arida A, Bournia VK, Fragiadaki K, Karamanakos A, Kravvariti E, Laskari K, Panopoulos S, Pappa M, Tektonidou MG, Sfikakis PP (2020) Treatment adherence of patients with systemic rheumatic diseases in COVID-19 pandemic. Ann Rheum Dis. https://doi.org/10.1136/annrheumdis-2020-217935

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Impact of COVID-19 on Influenza and Pneumococcal Vaccination of Psoriatic Patients in Germany: Results from Vac-Pso;Vaccines;2024-06-04

2. Do Not Leave Your Patients in the Dark—Using American College of Rheumatology and European Alliance of Associations for Rheumatology Recommendations for Vaccination in Polish Adult Patients with Autoimmune Inflammatory Rheumatic Diseases;Vaccines;2023-12-14

3. Flu vaccination coverage in Italy in the COVID-19 era: A fuzzy functional k-means (FFKM) approach;Journal of Infection and Public Health;2023-11

4. Long-term safety of COVID vaccination in individuals with idiopathic inflammatory myopathies: results from the COVAD study;Rheumatology International;2023-06-23

5. COVID-19 and flu, exploring the infection of virus, the safety and attitudes of vaccination in pediatric patients with rheumatic diseases;2023-06-14